Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypotheses for an underlying mechanism.
David A
DA
Smith
Manju T
MT
Beier
D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002170:Canada; D003704:Dementia / Q000188:drug therapy*; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D017410:Practice Guidelines as Topic; D011358:Product Surveillance, Postmarketing; D012107:Research Design; D018967:Risperidone / Q000009:adverse effects*; D020521:Stroke / Q000139:chemically induced*; D014481:United States
D014150:Antipsychotic Agents; D018967:Risperidone